KCNH2 and tuberculosis: Giventhe urgent need for new agents to treat TB infections, therewas significant interest in the identification of a benzofuran seriesthat inhibited Pks13, a novel target for TB drugs.17 Although the initial lead molecule 1 had verygood in vivo efficacy, it had a clear hERG liability which suggestedpotential for cardiotoxicity.